Macrophage biology in the pathogenesis of Helicobacter pylori infection

Xiao Fei1,2, Nianshuang Li1,2, Xinbo Xu1,2

  • 1Department of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

PubMed

Insights

Helicobacter pylori infection causes gastric inflammation and cancer by evading macrophage defenses. Understanding these interactions is key to developing new treatments for H. pylori-associated diseases.

Area of Science:

  • Immunology
  • Gastroenterology
  • Microbiology

Background:

  • * Helicobacter pylori (H. pylori) infection is a primary cause of chronic gastric inflammation, peptic ulcers, and stomach adenocarcinoma.
  • * Macrophages are critical innate immune cells involved in host defense against bacterial pathogens.
  • * H. pylori employs specific mechanisms to evade phagocytosis, enabling gastric colonization and exacerbating preneoplastic pathology.

Purpose of the Study:

  • * To review recent findings on macrophage interactions during H. pylori infection.
  • * To elucidate the molecular mechanisms by which H. pylori influences macrophage polarization and function.
  • * To highlight how these interactions impact the clinical outcomes of H. pylori infection.

Main Methods:

  • * Literature review of studies investigating H. pylori and macrophage interactions.
  • * Analysis of molecular pathways governing macrophage polarization (M1/M2) in response to H. pylori.
  • * Examination of H. pylori's strategies for evading phagocytosis and promoting inflammation.

Main Results:

  • * H. pylori promotes gastric inflammation via oxidative stress and resistance to macrophage phagocytosis.
  • * H. pylori induces M1 macrophage polarization, contributing to inflammation.
  • * M2 macrophages are implicated in promoting gastric cancer cell proliferation, invasion, and migration.

Conclusions:

  • * Macrophage dysfunction is central to H. pylori pathogenesis, driving inflammation and cancer progression.
  • * Understanding H. pylori-induced macrophage polarization is crucial for therapeutic strategies.
  • * Targeting macrophage-pathogen interactions may offer novel approaches for managing H. pylori-associated gastric diseases.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
558
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
296
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
362
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
340
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
344
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K